Q3 2024 Holdings
Filed 2024-11-14 | 41 holdings | $123.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $15.5M | 135,400 | 12.5% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $10.4M | 1,190,071 | 8.4% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $8.5M | 332,095 | 6.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $7.8M | 107,500 | 6.4% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $7.6M | 296,368 | 6.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $6.7M | 131,700 | 5.5% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $5.2M | 62,100 | 4.2% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $5.2M | 1,260,700 | 4.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $4.9M | 108,000 | 4.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $4.3M | 2,118,992 | 3.4% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $4.1M | 487,000 | 3.3% |
| Kura Oncology Inc. Common Stock(KURA) | COM | 50127T109 | $3.8M | 197,000 | 3.1% |
| Aadi Biosciences Inc(WHWK) | COM | 00032Q104 | $3.8M | 1,849,402 | 3.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $3.5M | 190,000 | 2.8% |
| Praxis Precision Medicines I(PRAX) | COM | 74006W207 | $3.3M | 57,500 | 2.7% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $3.2M | 5,900 | 2.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $3.1M | 21,000 | 2.5% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $2.4M | 386,500 | 2.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $2.3M | 1,200,000 | 1.8% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $1.9M | 180,945 | 1.5% |
| Acelyrin Inc | COM | 00445A100 | $1.8M | 364,000 | 1.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $1.7M | 63,000 | 1.4% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $1.7M | 46,200 | 1.3% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $1.6M | 19,500 | 1.3% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $1.4M | 25,100 | 1.1% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $970.3K | 290,500 | 0.8% |
| Unicycive Therapeutics Inc | COM | 90466Y103 | $807.3K | 1,979,199 | 0.7% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $735.0K | 73,500 | 0.6% |
| Verve Therapeutics Inc | COM | 92539P101 | $707.1K | 146,100 | 0.6% |
| Geron Corp(GERN) | COM | 374163103 | $703.2K | 154,900 | 0.6% |
| Celcuity Inc(CELC) | COM | 15102K100 | $694.8K | 46,600 | 0.6% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $679.8K | 44,000 | 0.6% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $415.1K | 13,700 | 0.3% |
| Corbus Pharmaceuticals Holdings(CRBP) | COM NEW | 21833P301 | $381.7K | 18,500 | 0.3% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $360.4K | 17,600 | 0.3% |
| Leap Therapeutics Inc(CYPH) | COM NEW | 52187K200 | $309.7K | 120,500 | 0.3% |
| Climb BIO Inc(CLYM) | COM | 28658R106 | $274.9K | 54,000 | 0.2% |
| Benitec Biopharma Inc(BNTC) | COM NEW | 08205P209 | $273.9K | 29,800 | 0.2% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $265.8K | 19,000 | 0.2% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $210.1K | 15,508 | 0.2% |
| Nuvation BIO Inc -Cw27(NUVB/WS) | *W EXP 07/07/2027 | 67080N119 | $8.9K | 90,832 | 0.0% |